Keros Therapeutics, Inc. (KROS): SC 13G/A filed Apr 12, 2022

Form type

SC 13G/A

Filing date

Apr 12, 2022

Accession number

0001178913-22-001489

Filer

Keros Therapeutics, Inc. (CIK 1664710)